Serina Therapeutics

About Serina Therapeutics

Serina Therapeutics is a clinical-stage biotechnology company focused on using next-generation polymer science to optimize the performance of small molecule therapeutics in the body. Their mission is to transform good molecules into great medicines through their proprietary POZ Platform™, enhancing drug delivery, reducing side effects, and improving patient experience, with a particular emphasis on advanced Parkinson's disease treatments.

Products & Services

POZ Platform™:A proprietary polymer platform that enables precise, controlled, and sustained drug exposure, improving pharmacokinetics, reducing dosing frequency, and minimizing side effects. It is customizable and can be administered via IV, SC, or IM routes for various clinical indications.

SER-252 (POZ-Apomorphine):A lead candidate for advanced Parkinson's disease, utilizing POZylation to offer a discreet, twice-weekly subcutaneous injection, replacing complex infusion therapies and maintaining patients in an 'on' state 24/7.

SER-270:An additional product in development, though specific details are not provided in the content.

Specialties

Polymer-based drug optimization POZylation technology Central Nervous System (CNS) indications Parkinson's disease treatment RNA medicines in vaccine immunology, cancer immunoRX, and gene therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Milestone-based financing T: - FT: Milestone-based financing	A: 5000000 MR: - FA: $5 million FAN: 5000000	D: 2025-10-06 FD: 2025-10-06	-
2	RT: Convertible Note T: - FT: Convertible Note	A: 20000000 MR: - FA: up to $20 million FAN: 20000000	D: 2025-09-09 FD: 2025-09-09	1 investors

Milestone-based financing Latest

2025-10-06

$5.0M

Convertible Note 2025-09-09

$20.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Simba Gill

Executive Chairman

S

Steve Ledger

CEO and Director

G

Gregory Bailey

Director

R

Richard Marshall

Director

S

Steve Brannan

Director

K

Karen J. Wilson

Director

View 10 more team members with Pro

Unlock Full Team Directory

Recent News